Variation in Serum PCSK9, Cardiovascular Disease Risk and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition: A GWAS and Mendelian Randomization Study in the Nord-Trøndelag Health Study, Norway

Guardado en:
Detalles Bibliográficos
Publicado en:Circ Genom Precis Med
Autores principales: Brumpton, Ben M., Fritsche, Lars G., Zheng, Jie, Nielsen, Jonas Bille, Mannila, Maria, Surakka, Ida, Rasheed, Humaira, Vie, Gunnhild Åberge, Graham, Sarah E., Gabrielsen, Maiken Elvestad, Laugsand, Lars Erik, Aukrust, Pål, Vatten, Lars Johan, Damås, Jan Kristian, Ueland, Thor, Janszky, Imre, Zwart, John-Anker, van ´t Hooft, Ferdinand M., Seidah, Nabil Georges, Hveem, Kristian, Willer, Cristen, Smith, George Davey, Åsvold, Bjørn Olav
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6530796/
https://ncbi.nlm.nih.gov/pubmed/30645169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCGEN.118.002335
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares